Na+/K+-ATPase: a multifunctional target in type 2 diabetes and pancreatic islets DOI Creative Commons
Lisha Mou, Zhenkun Fu,

Tony Bowei Wang

et al.

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 16

Published: Feb. 19, 2025

Type 2 diabetes (T2D) is a widespread metabolic disorder marked by hyperglycemia, arising from insulin resistance and relative deficiency. This review investigates the critical role of Na+/K+-ATPase (NKA), transmembrane protein essential for maintaining cellular ion gradients, in pathophysiology T2D. We provide an overview NKA's biological functions, emphasizing its involvement signaling pathways, secretion, glucose homeostasis. The potential NKA as therapeutic target T2D analyzed, showcasing innovative strategies such activators, gene therapy, stem cell therapy aimed at enhancing activity to achieve better glycemic control. Additionally, multifunctional viability modulating immune responses islet transplantation may offer benefits improving transplant outcomes. By elucidating complex interactions between T2D, this aims shed light on developing novel interventions that meet multifaceted needs individuals suffering chronic condition, ultimately their health

Language: Английский

Alpha-Lipoic Acid Treatment Reduces the Levels of Advanced End Glycation Products in Type 2 Diabetes Patients with Neuropathy DOI Creative Commons

Sára Csiha,

Marcell Hernyák,

Ágnes Molnár

et al.

Biomedicines, Journal Year: 2025, Volume and Issue: 13(2), P. 438 - 438

Published: Feb. 11, 2025

Background/Objectives: Type 2 diabetes mellitus (T2DM) and its macro- microvascular complications are major health concerns with multiple factors, like advanced end glycation products (AGEs), in the background. AGEs induce long-lasting functional modification of proteins collagen vascular wall nerve tissue. We investigated effect alpha-lipoic acid (ALA) treatment on AGEs, soluble AGE receptor (sRAGE), AGE/sRAGE ratio, parameters endothelial dysfunction their correlations. Methods: In our 6-month intervention study, 54 T2DM patients neuropathy treated according to actual therapeutic guidelines unchanged oral antidiabetic drugs were included by daily administration 600 mg ALA. A total 24 gender age-matched without served as controls. Results: work, we first demonstrated attenuating alpha lipoic therapy humans (11.89 (9.44–12.88) 10.95 (9.81–12.82) AU/μg (p = 0.017)). sRAGE levels or AGEs/sRAGE ratio not affected ALA presence neuropathy. found a correlation between changes improvement current perception threshold progranulin levels, an inverse change asymmetric dimethylarginine. Conclusions: According results, decreases which may contribute clinically well-known beneficial diabetic function.

Language: Английский

Citations

0

Exploring the Therapeutic Potential of Antibiotics in Hyperglycemia-Induced Macrophage Dysfunctions DOI Creative Commons
Montira Yossapol, Piyarat Srinontong, Worapol Aengwanich

et al.

Antibiotics, Journal Year: 2025, Volume and Issue: 14(2), P. 198 - 198

Published: Feb. 14, 2025

Background: Diabetes mellitus exacerbates immune dysfunction, leading to higher susceptibility infections. This study investigated the effects of antibiotics on macrophage functions under high glucose conditions mimic a diabetic context. Methods: Using murine cell line RAW 264.7, present evaluated cytotoxicity, phagocytosis, bactericidal activity, and pro-inflammatory cytokine production after treatment with four antibiotics: oxytetracycline, ciprofloxacin, sulfamethoxazole-trimethoprim, cefotaxime. Results: All demonstrated no cytotoxicity across 1×-8× MIC concentrations. Hyperglycemia significantly impaired phagocytosis activity while inducing mediator markers, IL-1, IL-6, TNF-α, iNOS. Only ciprofloxacin improved phagocytic achieving levels comparable low control. Treatments cefotaxime enhanced without altering profile. Conclusions: These findings underscore negative effect suggest that may be potential therapeutic option for diabetes-associated

Language: Английский

Citations

0

In vitro antidiabetic activity of Treculia africana leaf extracts: identification of chlorogenic acid and α-mangostin DOI
Victorine Lorette Yimgang,

Elisa Pangrazzi,

Francine Medjiofack Djeujo

et al.

Journal of Pharmacy and Pharmacology, Journal Year: 2025, Volume and Issue: unknown

Published: Feb. 14, 2025

This research studied two extracts from Treculia africana leaves for their potential against hyperglycaemia-related disorders. The influence of the on α-glucosidase activity and albumin glycation was investigated, cell viability estimated in HT-29 human colorectal cells. Phenolic flavonoid contents antiradical were also detected. examined using HPLC-DAD analysis. methanol dichloromethane leaf showed a significant concentration-dependent inhibition (IC50= 3.73 21.28 µg/ml, respectively). Both inhibited ribose-induced bovine serum 250 µg/ml. Phytochemical analysis revealed presence chlorogenic acid α-mangostin extracts. did not change up to thus showing very low cytotoxicity. extract T. manner, supporting use traditional medicine control hyperglycaemia. Chlorogenic α-mangostin, latter identified first time this species, found leaves. Further, vivo studies pilot clinical trials should be conducted standardized evaluate effectiveness diabetes mellitus.

Language: Английский

Citations

0

Melioidosis in people living with diabetes; clinical presentation, clinical course and implications for patient management DOI Creative Commons

Lani Prideaux,

Megan Sandeman,

H. J. M. Stratton

et al.

Acta Tropica, Journal Year: 2025, Volume and Issue: unknown, P. 107559 - 107559

Published: Feb. 1, 2025

Language: Английский

Citations

0

Na+/K+-ATPase: a multifunctional target in type 2 diabetes and pancreatic islets DOI Creative Commons
Lisha Mou, Zhenkun Fu,

Tony Bowei Wang

et al.

Frontiers in Immunology, Journal Year: 2025, Volume and Issue: 16

Published: Feb. 19, 2025

Type 2 diabetes (T2D) is a widespread metabolic disorder marked by hyperglycemia, arising from insulin resistance and relative deficiency. This review investigates the critical role of Na+/K+-ATPase (NKA), transmembrane protein essential for maintaining cellular ion gradients, in pathophysiology T2D. We provide an overview NKA's biological functions, emphasizing its involvement signaling pathways, secretion, glucose homeostasis. The potential NKA as therapeutic target T2D analyzed, showcasing innovative strategies such activators, gene therapy, stem cell therapy aimed at enhancing activity to achieve better glycemic control. Additionally, multifunctional viability modulating immune responses islet transplantation may offer benefits improving transplant outcomes. By elucidating complex interactions between T2D, this aims shed light on developing novel interventions that meet multifaceted needs individuals suffering chronic condition, ultimately their health

Language: Английский

Citations

0